Connor, Clark & Lunn Investment Management Ltd.
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 1596800
VANCOUVER, A1
Position in PACB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$585,183
+$30,011 QoQ
Shares Held
348,324
+135.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 222 holders
Holding Since
Dec 2020
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. PACB ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
869,131 | $78,864,946 | |
| 2 | BSX |
Boston Scientific Corp
|
1,467,148 | $62,617,875 | |
| 3 | PHG |
Koninklijke Philips NV
|
563,724 | $15,327,654 | |
| 4 | SNN |
Smith & Nephew PLC
|
487,774 | $14,052,767 | |
| 5 | NVCR |
NovoCure Ltd
|
661,280 | $10,018,391 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
42,314 | $5,033,250 | |
| 7 | AXGN |
Axogen, Inc.
|
67,118 | $3,100,180 | |
| 8 | VREX |
Varex Imaging Corp
|
293,435 | $3,060,526 |
All Filings in PACB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $585,183 | 348,324 | Shares | Sole | 2026-08-13 | |
| 2024-03-31 | $555,172 | 148,046 | Shares | Sole | 2024-05-09 | |
| 2020-12-31 | $5,343,821 | 206,007 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||